Currently, a few studies have reported on the expression of FSCN1 in liver cancer, showing that FSCN1 is highly expressed in both HCC and ICC, and is associated with poor patient prognosis8–11. This evidence concerns the gene FSCN1 and intrahepatic cholangiocarcinoma.